NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/17/2026
Back to search
Official data from USPTO
ALIVE MEDICAL AMPLIFY YOUR LIFE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
03/17/2026
Trademark type
Combined
Nice classes
44
Filing date
11/11/2022
Registration date
03/17/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/17/2026
Last transaction
03/17/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/04/2024
First use in commerce
12/04/2024
Drawing code
3
Owner type
16
Owner location
SEBASTOPOL, CA, US
Examiner
CHANG, KATHERINE S
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized word "ALIVE" with the "IVE" portion appearing on a cross that leans to the right. Below the "ALI" portion is the word "MEDICAL" and below that is the wording "AMPLIFY YOUR LIFE". All of the foregoing appears on a rectangular background.
Holders and representatives
Holders
ALIVE MEDICAL MANAGEMENT, LLC
Representatives
Daren P. Nicholson SAFFIRE IP
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Intravenous (IV) hydration therapy services
Publications
History of USPTO decisions and trademark events.
40 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/17/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/26/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/26/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/26/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/26/2026
ALIE
ASSIGNED TO LIE
02/26/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/24/2026
EEXT
SOU TEAS EXTENSION RECEIVED
12/01/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/24/2025
GNRT
NON-FINAL ACTION E-MAILED
11/24/2025
CNRT
SU - NON-FINAL ACTION - WRITTEN
11/24/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/20/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/15/2025
IUAF
USE AMENDMENT FILED
06/09/2025
EISU
TEAS STATEMENT OF USE RECEIVED
06/09/2025
EX2G
SOU EXTENSION 2 GRANTED
06/02/2025
EXT2
SOU EXTENSION 2 FILED
06/02/2025
EEXT
SOU TEAS EXTENSION RECEIVED
06/02/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/03/2025
EX1G
SOU EXTENSION 1 GRANTED
12/03/2024
EXT1
SOU EXTENSION 1 FILED
12/03/2024
EEXT
SOU TEAS EXTENSION RECEIVED
12/02/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/04/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/09/2024
PUBO
PUBLISHED FOR OPPOSITION
04/09/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/20/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/04/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/01/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/01/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/01/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
11/28/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
11/28/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/01/2023
GNRT
NON-FINAL ACTION E-MAILED
09/01/2023
CNRT
NON-FINAL ACTION WRITTEN
09/01/2023
DOCK
ASSIGNED TO EXAMINER
08/25/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
12/06/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/03/2022
NWAP
NEW APPLICATION ENTERED
11/15/2022
Continuous trademark protection
Get notified about every new filing that threatens ALIVE MEDICAL AMPLIFY YOUR LIFE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.